Navigation Links
Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
Date:2/5/2013

KANSAS CITY, Kan. and BOSTON, Feb. 5, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will present at two upcoming healthcare conferences.  Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with potential collaborators. 

Aratana has been selected as one of a few privately held companies to present at the 2013 BIO CEO and Investor Conference, to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York.  Event:BIO CEO and Investor ConferenceDate: Tuesday, February 12, 2013 Time: 9:45 am (Eastern Time) Location:Park South; Waldorf Astoria Hotel; New YorkThe Company will also present at the Leerink Swann Global Healthcare Conference, to be held February 13-14, 2013, also at the Waldorf Astoria Hotel.  Event:Leerink Swann Global Healthcare ConferenceDate: Thursday, February 14, 2013 Time: 2:30 pm (Eastern Time) Location:Morgan Suite; Waldorf Astoria Hotel; New YorkDr. St. Peter will be joined by Louise Mawhinney , CPA, Chief Financial Officer; Linda Rhodes , V.M.D., Ph.D., Chief Scientific Officer; Julia Stephanus , Chief Commercial Officer; and Erick Lucera , Vice President, Corporate Development of Aratana Therapeutics.About Aratana TherapeuticsAratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com 
amielach@tiberend.com


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
2. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
3. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
4. Aratana to Participate in Leerink Swanns November Management Access Days
5. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
6. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
7. Prime Therapeutics named a 2013 National Top Workplace
8. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
9. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
10. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
11. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... PORTLAND, Ore. , May 9, 2017 /PRNewswire/ ... company that provides technology solutions to improve the ... reported financial results for the first quarter ended ... that our products enable our customers to identify ... them to intervene before events like heart attacks ...
(Date:5/8/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its acquisition ... care service center company based in Chantilly, ... management programs for leading pharmaceutical manufacturers and health care ... will join Envoy Health Management, LLC , as ... firms, and other service companies. Together, WRB and EnvoyHealth ...
(Date:5/6/2017)... is Stroke Awareness Month and Omron Healthcare is reminding ... prevent a stroke: monitor and manage your blood pressure. ... undetected and uncontrolled hypertension is a leading risk factor ... personal heart health technology, recently evolved its mission to ... and is advancing a national public education effort to ...
Breaking Medicine Technology:
(Date:5/28/2017)... ... May 28, 2017 , ... ... proud to announce that Sheldon K. Cho, MD, has joined its Winter Haven ... specialty that concentrates on minimally invasive techniques to treat and manage many types ...
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... doctor for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain ... doctors may be largely responsible for the problem both in Canada and the United ...
(Date:5/27/2017)... ... May 27, 2017 , ... In any business, follow up is ... of your dental team at presenting treatment, there will always be some patients who ... time and money on best practices when it comes to presenting treatment. After ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson ... more than eighty-nine grant submissions all vying for nearly $1,000,000 in funding that ... field.     , The American Parkinson Disease Association (APDA) is focused on advancing scientific ...
Breaking Medicine News(10 mins):